Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis

BACKGROUND: Lymphangioleiomyomatosis (LAM) is a progressive lungs disease that affects women at reproductive years. Sirolimus inhibits mammalian target of rapamycin (mTOR) and its administration in past studies was hopeful in treatment of patients with LAM. The aim of this study was to evaluate siro...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghaeimeybodi, Fatemeh, Najafizadeh, Katayoun, Razavi-Ratki, Seyd-Kazem, Namiranian, Nasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386328/
https://www.ncbi.nlm.nih.gov/pubmed/30858935
http://dx.doi.org/10.22088/cjim.10.1.7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386328/
https://www.ncbi.nlm.nih.gov/pubmed/30858935
http://dx.doi.org/10.22088/cjim.10.1.7

Ejemplares similares